Currently, the stock price of Iovance Biotherapeutics Inc (IOVA) is $2.11. In the most recent trading session, the stock underwent a significant upswing, peaking at $20.0 after opening at $2.11. The stock touched a low of $1.0 before closing at $2.64.
In terms of market performance, Iovance Biotherapeutics Inc had a somewhat inconsistent run in.
52-week price history of IOVA Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Iovance Biotherapeutics Inc’s current trading price is -83.13% away from its 52-week high, while its distance from the 52-week low is 28.78%. The stock’s price range for this period has remained between $1.64 and $12.51. The Healthcare sector company’s shares managed to surpass a trading volume of around 43.38 million for the day, which was noticeably higher compared to the shares’ average daily volume of 18.95 million over the last three months.
Financial Performance and Market Capitalization
Iovance Biotherapeutics Inc (IOVA) has experienced a quarterly decline of -33.44% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 763.51M and boasts a workforce of 838 employees.
Analysts’ Ratings For Iovance Biotherapeutics Inc
As of right now, 5 analysts are rating Iovance Biotherapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.58, with a change in price of -1.63. Similarly, Iovance Biotherapeutics Inc recorded 15,714,352 in trading volume during the last 100 days, posting a change of -43.58%.
IOVA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for IOVA stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.06.
IOVA Stock Stochastic Average
As of today, the raw stochastic average of Iovance Biotherapeutics Inc over the last 50 days is at 16.85%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 15.59%. Further, the company’s Stochastic %K and %D values for the last 20 days were 28.26% and 34.50%, respectively.
IOVA Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price decrease of -72.74%. However, over the past six months, we’ve seen a stronger performance of -64.12%. The price of IOVA fallen by 9.33% over the last 30 days. And in the last five days, it has fallen by -21.27%.
